Firategrast (SB 683699) is an orally active and specific alpha4beta1/alpha4beta7 integrin antagonist. Firategrast reduces trafficking of lymphocytes into the central nervous system (CNS) and decreases multiple sclerosis (MS) activity[1][2][3].
Molecular Weight:
499.50
Purity:
99.62
CAS Number:
[402567-16-2]
Formula:
C27H27F2NO6
Target:
Integrin
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted